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Summary
Background.— Many studies performed in adults have reported the involvement of genetic
determinants in vascular alterations that predispose to cardiovascular diseases later in life.
To date, no study has assessed the co-involvement of gene polymorphisms as cardiovascular
risk factors in children.
Aims.— To search for variants involved in early vascular alterations in obese children.
Methods.— In 232 obese children, we performed an association study between variables related
to endothelial function or arterial mechanical properties and functional variants reported to
predispose towards vascular alterations in adults. Candidate polymorphisms were selected in
genes involved in the renin—angiotensin system, vascular endothelial cell remodelling and
communication, arterial inﬂammation, adiponectin production and lipoprotein metabolism.
Non-invasive arterial measurements were performed to evaluate the mechanical characteristics
of the common carotid artery and the endothelial function of the brachial artery.
Abbreviations: ACE, angiotensin I-converting enzyme; AGT, angiotensinogen; AGTR1, angiotensin II type1 receptor; APM1, adiponectin;
X37, connexin; CX3CR1, fractalkine receptor; dD, diastolic diameter; DWS, diastolic wall stress; Einc, incremental elastic modulus; FMD,
ow-mediated dilation; GTNMD, glyceryltrinitrate-mediated dilation; I/D, insertion/deletion; IMT, intima-media thickness; LCSA, lumen
ross-sectional area; MMP3, stromelysin-1; NOS3, nitric oxide synthase 3; P, pulse pressure; PAI-1, plasminogen-activator inhibitor type
; PON1, paraoxonase 1; sD, systolic diameter; SNP, single nucleotide polymorphism.
∗ Corresponding author. Fax: +33 1 44 73 62 28.
E-mail address: p.tounian@trs.aphp.fr (P. Tounian).
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Results.— We found no association between the polymorphisms studied, taken alone or in
combination with the arterial variables measured.
Conclusion.— Our hypothesis predicting that the tested genetic variants, which are involved in
adult cardiovascular diseases, may inﬂuence the susceptibility to early vascular alterations in
obese children was not validated. Thus, obesity-associated metabolic complications appear to
remain the main predictors of arterial alterations in obese children.
© 2009 Elsevier Masson SAS. All rights reserved.
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Résumé
Contexte.— De nombreuses études réalisées chez l’adulte ont permis de mettre en évidence
l’implication d’une composante génétique dans la survenue et la progression d’altérations vas-
culaires à l’origine de cardiopathies ultérieures. À ce jour, aucune étude visant à mettre en
évidence des marqueurs génétiques précoces du risque cardiovasculaire n’a été réalisée chez
l’enfant.
But de l’étude.— Rechercher des marqueurs génétiques de lésions vasculaires précoces dans
notre cohorte d’enfants obèses.
Méthodes.— Une étude d’association entre des paramètres de la fonction endothéliale et de
la mécanique artérielle et des variants fonctionnels préalablement associés à des lésions car-
diovasculaires chez l’adulte a été menée chez 232 enfants obèses. Les polymorphismes ont
été choisis dans des gènes impliqués dans le système rénine—angiotensine, le remodelage
vasculaire, les jonctions entre cellules endothéliales, l’inﬂammation artérielle, la sécrétion
d’adiponectine et le métabolisme des lipoprotéines. Au site artériel carotidien, ont été mesurés
par échographie vasculaire de haute résolution les caractéristiques de la mécanique artérielle.
Au site artériel brachial, la fonction endothéliale a été évaluée par la vasodilatation induite
par l’hyperhémie provoquée.
Résultats.— Aucune association entre les polymorphismes étudiés, pris individuellement ou en
combinaison, et les caractéristiques artérielles phénotypiques des enfants obèses étudiés n’a
pu être mise en évidence.
Conclusion.— Les variants sélectionnés ne semblent pas intervenir dans la survenue des lésions
précoces des enfants obèses de notre cohorte. La réplication de cette étude dans une cohorte
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Introduction
The presence of early arterial alterations has been widely
studied in obese children [1—3]. These vascular alter-
ations lay the foundations for atherosclerosis and favour
adverse adult cardiovascular outcome, independent of adult
weight [4,5]. Metabolic disorders (insulin resistance, abnor-
mal plasma lipids) and inﬂammatory conditions associated
with excess fat mass — especially visceral fat — are
surely involved in the occurrence of these early arterial
lesions [1—3]. Besides these conventional risk factors, the
so-called atherosclerotic ‘‘burden’’ also involves a predis-
posing genetic background, as suggested by twin-, sibling-
and family-based studies [6,7], as well as candidate-gene
analyses, performed in adults [8]. So far, no study has been
designed to identify the involvement of several polymor-
phisms, alone or in combination, in the susceptibility to
precocious endothelial dysfunction and arterial mechani-
cal property abnormalities in children. It stands to reason
that such a study has to be performed, ﬁrstly because
the foundations of atherosclerosis are laid as early as
childhood, and secondly because factors that act early in
life have a major impact on lifetime risk of cardiovascu-
lar disease [5,9,10]. Furthermore, it is worth investigating
whether genetic variants implicated in vascular alterations
in adults have an impact in obese children who are already
m
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oour conﬁrmer ou inﬁrmer ces données.
s droits réservés.
resenting with vascular conditions caused by obesity
1—3].
The present study was undertaken to assess the contri-
ution of speciﬁc genetic variants, known to predispose
owards cardiovascular diseases in adults, to vascular alter-
tions in obese children.
aterials and methods
tudy population
his association study was performed in a cohort of 232
nrelated severely obese children recruited prospectively
ver 5 years at our outpatient department. This cohort was
xtended by 60 more children for the AGTR1 A1166C poly-
orphism, to further explore the trend of the association
etween the C allele and several arterial and endothe-
ial parameters revealed by the ﬁrst statistical analyses.
evere obesity was deﬁned as a body mass index Z-score
3 (standard deviation over mean age and sex-speciﬁc body
ass index values determined in French children by Rolland-
achera et al. [11]).
The protocol was approved by the institutional review
oard and written informed consent was obtained from the
lder children and from both parents of all children.
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esign and procedures
aseline anthropometric and metabolic
haracteristics of obese subjects
lood samples were collected from the children after an
vernight fast to determine plasma glucose, insulin, lipid
roﬁle (total cholesterol, triglycerides, low-density lipopro-
ein, high-density lipoprotein, and apolipoprotein B and
-1), ferritin and leptin by routine laboratory procedures as
escribed previously [1,12]. Insulin sensitivity was evaluated
sing homeostasis model assessment (HOMA), a surrogate
easure of insulin sensitivity validated in children [13].
nthropometric data (Tanner stage, weight, height) were
ollected. Body fat mass was measured by dual-energy
-ray absorptiometry with a total-body scanner (QDR 2000-
OLOGIC, Waltham, MA, USA). Percentage body fat was
alculated as 100× total body fat mass/total body mass. To
valuate the effects of fat distribution, the body was divided
nto areas corresponding to arms, legs, trunk and head. The
runk region was delineated by an upper horizontal border
elow the chin, vertical borders lateral to the ribs and a
ower border formed by the oblique lines passing through the
ip joints. The leg region was deﬁned as the tissue below the
blique lines passing through the hip joints. Body fat distri-
ution was calculated as the ratio of the amount of fat tissue
n the trunk region over the amount of fat tissue in the leg
egion, and was deﬁned as android/gynoid fat mass ratio.
rterial measurements
single investigator (YA), who used a real-time B-mode
ltrasound imager (Acuson XP 128, Mountain View, CA,
SA) performed non-invasive arterial measurements. IMT
nd lumen diameters during dD and sD were measured
t the common carotid artery as described previously [1].
CSA was calculated as dD2/4 and wall cross-sectional
rea (WCSA) as (dD/2 + IMT)2 −(dD/2)2. Cross-sectional
ompliance (CSC) and cross-sectional distensibility (CSD)
f the common carotid artery were determined from
iameter changes during systole and from simultaneously
easured pulse pressure (P), according to the fol-
owing formulae: CSC = ([sD2 −dD2])/4P (mm2 mmHg−1);
nd CSD = (sD2 −dD2)/(dD2 ×P) (mmHg−1 × 10−2). P was
easured using applanation tonometry during arterial
easurements. DWS was calculated as mean arterial pres-
ure×dD/2× IMT. Incremental elastic modulus (Einc) was
alculated as 3× [1 + LCSA/WCSA])/CSD (mmHg× 102). In
ontrast to compliance, which provides information about
lasticity of the artery as a hollow structure, the Einc pro-
ides information about the properties of the wall material,
ndependent of the geometry.
After at least 30min of rest in a recumbent position, arte-
ial endothelial function was studied using a high-resolution
ascular ultrasound system. The investigator measured FMD,
eﬁned as arterial diameter changes in response to reactive
yperaemia (endothelium-dependent vasodilation induced
y a ﬂow increase); and GTNMD, deﬁned as arterial diam-
ter changes in response to the endothelium-independent
asodilator glyceryltrinitrate. Reactive hyperaemia was
nduced by inﬂating a blood pressure cuff to 300mmHg for
min; the artery was scanned for 30 s before and 90 s after
uff deﬂation. A resting scan was recorded 10m later. Glyc-
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ryltrinitrate (400g spray) was then given sublingually and
he artery was scanned 3min after the dose.
election of polymorphisms and genotyping
ith the use of the public databases PubMed® (www.ncbi.
lm.nih.gov/entrez/query.fcgi?db=Pubmed) and Online
endelian Inheritance in Man (www.ncbi.nlm.nih.gov/
ntrez/query.fcgi?db=OMIM), we selected variants reported
reviously to be associated with vascular endothelial
ysfunction and artery mechanical property alterations in
dults. These polymorphisms are located in genes coding
or proteins involved in the renin—angiotensin system (ACE
/D, AGT G-6A and Met235Thr, AGTR1 A1166C), vascular
ndothelial cell remodelling (MMP3 5A/6A, PAI-1 4G/5G),
ell junction and communication (CX37 Pro319Ser), leu-
ocyte adhesion during inﬂammation (CX3CR1 Val249Ile),
rterial vasodilation (NOS3 Glu298Asp), adiponectin secre-
ion (APM1 C-11377G and C-11391G) and lipoprotein
etabolism (PON1 Glu192Arg).
All polymorphisms were SNP except for the ACE I/D,
hich corresponds to the insertion of an Alu-like repeti-
ive sequence into intron 16 [14]. These polymorphisms are
ocated either in the promoter region or in introns or exons
nd have been shown to cause changes in the function or lev-
ls of expression of the encoded protein; the variant allele
as reported to occur at least in 5% of the population in
revious studies.
The subjects’ DNA was extracted from ethylenedi-
minetetraacetic acid whole blood samples using the
uregen kit (Gentra Systems, Minneapolis, MN, USA). The
NPs were genotyped with the LightCyclerTM (Roche Diagnos-
ics, Basel, Switzerland) based on probes and ﬂuorescence
esonance energy transfer between ﬂuorescein and LC Red
40 (Roche Diagnostics). Primers and hybridization probes
ere designed by TIB MolBiol Syntheselabor (Berlin, Ger-
any). Detailed experimental conditions are available from
he authors.
The ACE I/D polymorphism was determined according the
echnique developed by Marre et al. [15].
ata analyses
he number of subjects included (n = 232) was sufﬁcient
o detect, with a power of 80%, a 4% variation (threshold
ased on previous results of our own [1]) of the ﬂow-
ediated dilation trait, deﬁned as the more relevant marker
f endothelial function, assuming a recessive genetic model
or each polymorphism.
The Chi-square test was applied to check compliance with
he Hardy-Weinberg equilibrium of each allele frequency
nd that no difference in genotype distribution of each poly-
orphism was present between sexes. Quantitative trait
ata are expressed as mean± standard error of the mean.
he Gaussian distribution of each variable was tested with
he Shapiro-Wilk test. For distributions skewed positively, a
og-transformation was applied before the statistical tests
ut untransformed values are given in tables.Associations between genotypes (each allele or hap-
otype alone and combinations of alleles when possible)
nd phenotype traits were tested with the general linear
odel analysis of covariance (least-square mean regres-
ion) with adjustments on covariates as follows: age,
en 13
Table 2 Structural and mechanical properties of the
common carotid artery and endothelial function of the
brachial artery in obese children (n = 232).
Measurement
Arterial measurements
Systolic diameter (mm) 6.02 ± 0.72
Diastolic diameter (mm) 5.36 ± 0.51
Intima-media thickness (mm) 0.46 ± 0.05
Common carotid artery mechanical indexes
Lumen cross-sectional area
(mm2)
22.51 ± 5.11
Wall cross-sectional area
(mm2)
8.31 ± 1.61
Cross-sectional compliance
(mm2 mmHg)
0.12 ± 0.04
Cross-sectional distensibility
(mmHg−1 × 10−2)
0.60 ± 0.70
Diastolic wall stress 3.18 ± 0.50Gene polymorphims and vascular alterations in obese childr
sex, Tanner stage, homeostasis model assessment, ferritin,
android/gynoid fat-mass ratio, leptin and lipid proﬁle. Each
genotype was assessed with the use of dominant, recessive
and additive genetic models.
All statistical analyses were performed with JMP software
(SAS Institute Inc, Cary, NC, USA). Statistical signiﬁcance was
deﬁned from p < 0.05.
Results
The baseline demographic, metabolic and haemodynamic
characteristics of the 232 severely obese children involved in
the study are shown in Tables 1 and 2. The average duration
of the obesity was 8.4± 3.1 years.
The prevalence of the 12 polymorphisms screened in our
population-based study is given in Table 3. As described pre-
viously in the literature [16], the A and C alleles of the AGT
G-6A and Met235Thr (a substitution of the T nucleotide for a
C, which changes the ATG codon coding for methionine into
an ACG codon coding for threonine) polymorphisms were
in very tight disequilibrium (D′ = 0.96; AC = 51%, GT = 47%).
The genotype frequencies for each polymorphism were in
Hardy-Weinberg equilibrium and in keeping with values
Table 1 Physical and biological characteristics of the
obese children (n = 232).
Characteristic
Demography
Sex (male/female) 82/150
Age (years) 11.4± 3.1
Anthropometry
Tanner stage 3 (1—5)
Weight (kg) 75.8± 27.5
Height (cm) 151.3± 16.9
Body mass index Z-score 4.57± 1.17
Android/gynoid fat mass ratio 1.02± 0.21
Blood pressure (mmHg)
Systolic 115.3± 10.5
Diastolic 59.7± 9.8
Metabolic variables
Fasting glucose (mmol/L) 4.89± 0.51
Fasting insulin (UI/mL) 16.4± 11.6
HOMA 3.3± 2.8
Leptin (ng/mL) 27.4± 13.3
Total cholesterol (mmol/L) 4.33± 0.77
LDL-cholesterol (mmol/L) 2.48± 0.71
Apolipoprotein B (g/L) 0.75± 0.19
HDL-cholesterol (mmol/L) 1.26± 0.27
Apolipoprotein A1 (g/L) 1.04± 0.20
Triglycerides (mmol/L) 0.88± 0.47
Lipoprotein (mg/L) 257± 240
Ferritin (g/L) 56.6± 32.9
Data are mean± standard error of the mean, number or median
(range).
HOMA: homeostasis model assessment of insulin resistance;
LDL: low-density lipoprotein; HDL: high-density lipoprotein.
(mmHg× 102)
Incremental elastic modulus
(mmHg× 103)
2.51 ± 1.36
Endothelial function
Flow-mediated dilation (%) 6.0 ± 3.0
Glyceryltrinitrate-mediated
dilation (%)
17.1 ± 8.0
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eported in the National Centre for Biotechnology Infor-
ation, Entrez Single Nucleotide Polymorphisms Data Bank
www.ncbi.nlm.nih.gov/entrez/query.fcgi?CMD=search&DB
snp). There were no signiﬁcant differences between
ifferent genotypes within the cohort with respect to age,
ex, anthropometric or metabolic estimates, or obesity
omorbidities.
Multivariable logistic-regression analysis with adjust-
ents for covariates failed to show that the 12 polymor-
hisms, taken alone or in combination, had any impact
ither on the geometrical and mechanical characteristics
f the common carotid artery or the endothelial function
f the brachial artery (Table 4). The trend of association
etween the AGTR1 1166C allele, in a dominant model, and
ommon carotid artery compliance (CSC, p = 0.06) and dis-
ensibility (CSD, p = 0.06), and Einc (p = 0.07), ﬁrst revealed
y the statistical analyses performed in the cohort of 232
hildren, was not conﬁrmed when 60 extra children were
dded. It is noteworthy that initial statistical analyses per-
ormed without adjustments also led to negative results.
rouping subjects according to age, sex, android or fat mass
istribution made no difference (data not shown).
iscussione examined, in 232 prospectively recruited obese chil-
ren, the relationships between 12 polymorphisms located
n candidate genes relevant to vascular alterations in adults,
nd the risk of early endothelial dysfunction and mechan-
cal property changes, which are markers of the arterial
14 A. Tounian et al.
Table 3 Distribution of genotypes for the 12 common polymorphisms studied in obese children.
Polymorphism Genotype n (%) n
AGT G-6A G/G G/A A/A 217
57 (26.27) 95 (43.78) 65 (29.95)
AGT Met235Thr T/T T/C C/C
57 (24.78) 105 (45.65) 68 (29.57) 230
AGTR1 A1166C A/A A/C C/C
187 (64.49) 85 (29.51) 16 (5.55) 288a
MMP3 5A -1171 6A 5A/5A 5A/6A 6A/6A
30 (13.04) 99 (43.04) 101 (43.91) 230
PAI-1 4G-675 5G 4G/4G 4G/5G 5G/5G
62 (27.68) 89 (39.73) 73 (32.59) 224
CX3CR1 Val249Ile G/G G/A A/A
134 (58.01) 79 (34.20) 18 (7.79) 231
PON1 Glu192Arg A/A A/G G/G
92 (40.00) 94 (40.87) 44 (19.13) 230
APM1 C-11377G C/C C/G G/G
135 (60.00) 80 (35.56) 10 (4.44) 225
APM1 G-11391A G/G A/G A/A
25 (11.11) 200 (88.89) 0 (0) 225
CX37 Pro319Ser C/C C/T T/T
51 (32.07) 75 (41.17) 33 (20.76) 159
NOS3 Glu298Asp G/G G/T T/T
84 (53.50) 57 (36.31) 16 (10.19) 157
ACE intron 16 I/D D/D I/D I/I
63 (39.62) 72 (45.28) 24 (15.10) 159
The group size differs from one polymorphism to the other due to genotyping pitfalls inherent in blood sampling conditions.
ACE: angiotensin I-converting enzyme; AGT: angiotensinogen; AGTR1: angiotensin II type1 receptor; APM1: adiponectin; CX37: connexin;
CX3CR1: fractalkine receptor; D/D: deletion/deletion; D/I: deletion/insertion; I/D: insertion/deletion; MMP3: stromelysin-1; NOS3:
nitric oxide synthase 3; PAI-1: plasminogen-activator inhibitor type 1; PON1: paraoxonase 1.
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amage that precedes plaque formation [2,3]. We found
o association between the arterial variables measured and
he polymorphisms studied, taken alone or in combina-
ion. Therefore, we cannot support the hypothesis that they
onfer, in either way, susceptibility to vascular alterations
n obese children.
The absence of a positive result provides an informative
onclusion, nevertheless. Indeed, the result may be wrongly
ttributed to statistical pitfalls due to the size of the cohort.
owever, the statistical differences were so far from signif-
cance (range 0.1—0.8) that it is more realistic to conclude
n absence of effect of the variants tested, rather than an
mpossibility to detect a possible effect. It is noteworthy
hat underpowered epidemiological studies lead more usu-
lly to statistical type I errors and to hastily drawn positive
usceptibility effects, which are not conﬁrmed in larger pop-
lations [17]. This explains why the trend towards a positive
ssociation between the AGTR1 1166C allele and CSC, CSD
inc, which was detected in the cohort of 232 children, was
ost when we added 60 extra children.
Thus, the positive associations described in previous
tudies, on which our own study is based, appear more
robably to be due to a gene expression and/or a phenotyp-
cal expression of the polymorphisms that occur at an older
ge [18,19]. For some of them, combination with conco-
itant expression of other variants [20,21] and/or other
d
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l
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Ionventional risk factors that are present to a lesser extent
n children (hypercholesterolaemia, hypertension, smoking,
rinking) [22,23] is required.
In light of the results of this survey, obesity per se [24],
etabolic disorders (insulin resistance, abnormal plasma
ipids) associated with adipose tissue (especially visceral
at) [2,9,10] and low-grade inﬂammation [25,26] remain the
ain predictors of the occurrence of early morphological
nd functional vascular changes. Previously, in a study based
n a subset of the cohort used in this paper, we reported that
ower arterial compliance and distensibility correlated pos-
tively with android fat distribution, which was associated
ith insulin resistance and plasma triglyceride concentra-
ion [1]. We also observed that altered endothelium function
orrelated with low plasma apolipoprotein A-1 and insulin
esistance indices [1]. Later, our results were conﬁrmed and
ompleted by others [27,28]. More recently, we extended
he previous cohort, and using three different deﬁnitions
f metabolic syndrome, we found that if metabolic factors
aken individually are associated with vascular dysfunction,
o synergistic effect is observed when they are combined to
eﬁne the metabolic syndrome [29]. The fact that metabolic
actors, which are known to be powerful in affecting vascu-
ar properties, failed to show a synergistic effect, illustrated
or us the difﬁculty in bringing a genetic effect to the fore.
ndeed, frequent polymorphisms, such as those we selected
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Table 4 Geometrical and mechanical characteristics of the common carotid artery and endothelial function of the brachial artery according to the genotype of the
different polymorphisms studied.
Polymorphism Intima-media
thickness (mm)
Cross-sectional
compliance
(mm2 mmHg−1)
Cross-sectional
distensibility
(mmHg−1 × 10−2)
Diastolic wall stress
(mmHg× 102)
Incremental elastic
modulus (mmHg× 103)
Flow-mediated
dilation (%)
GTN-mediated
dilation (%)
AGT G-6A
G/G 0.45 ± 0.01 0.11 ± 0.02 0.51 ± 0.05 3.09 ± 0.15 2.25 ± 0.29 5.29 ± 0.80 17.00 ± 1.82
G/A 0.46 ± 0.01 0.12 ± 0.01 0.53 ± 0.03 3.17 ± 0.08 2.37 ± 0.17 5.34 ± 0.48 14.95 ± 1.06
A/A 0.46 ± 0.01 0.11 ± 0.01 0.52 ± 0.06 3.28 ± 0.14 2.47 ± 0.29 5.03 ± 0.79 16.77 ± 1.77
AGTM235T
T/T 0.45 ± 0.01 0.11 ± 0.01 0.52 ± 0.05 3.26 ± 0.14 2.58 ± 0.28 5.08 ± 0.78 16.52 ± 1.76
T/C 0.46 ± 0.01 0.12 ± 0.02 0.52 ± 0.03 3.19 ± 0.08 2.47 ± 0.16 5.20 ± 0.43 15.39 ± 0.94
C/C 0.45 ± 0.01 0.11 ± 0.01 0.53 ± 0.04 3.12 ± 0.14 2.06 ± 0.29 5.51 ± 0.77 16.50 ± 1.70
AGTR1 A1166C
A/A 0.44 ± 0.01 0.11 ± 0.01 0.49 ± 0.02 3.15 ± 0.05 2.62 ± 0.15 5.30 ± 0.40 16.36 ± 0.72
A/C 0.45 ± 0.01 0.11 ± 0.01 0.51 ± 0.05 3.06 ± 0.07 2.59 ± 0.22 5.84 ± 0.67 16.70 ± 1.08
C/C 0.48 ± 0.04 0.08 ± 0.03 0.30 ± 0.02 3.65 ± 0.32 3.54 ± 0.95 7.84 ± 2.12 15.60 ± 2.94
MMP3 5A-1171 6A
5A/5A 0.45 ± 0.01 0.12 ± 0.01 0.49 ± 0.06 3.13 ± 0.16 2.59 ± 0.30 4.59 ± 0.90 14.18 ± 2.09
5A/6A 0.46 ± 0.01 0.13 ± 0.01 0.56 ± 0.03 3.08 ± 0.09 2.30 ± 0.19 5.36 ± 0.53 15.93 ± 1.21
6A/6A 0.46 ± 0.01 0.11 ± 0.01 0.49 ± 0.04 3.34 ± 0.09 2.46 ± 0.21 5.30 ± 0.53 16.27 ± 1.21
PAI-1 4G -675 5G
4G/4G 0.46 ± 0.05 0.10 ± 0.03 0.44 ± 0.02 3.11 ± 0.08 2.82v ± 0.17 5.41 ± 0.44 18.32 ± 1.41
4G/5G 0.46 ± 0.05 0.12 ± 0.03 0.52 ± 0.02 3.22 ± 0.07 2.59 ± 0.17 5.36 ± 0.37 16.25 ± 1.21
5G/5G 0.46 ± 0.04 0.12 ± 0.03 0.59 ± 0.01 3.21 ± 0.08 2.21 ± 0.19 5.98 ± 0.45 16.79 ± 1.41
CX3CR1 Val249Ile
G/G 0.45 ± 0.01 0.11 ± 0.01 0.52 ± 0.03 3.21 ± 0.07 2.46 ± 0.48 5.47 ± 0.41 16.36 ± 0.95
G/A 0.45 ± 0.01 0.13 ± 0.01 0.57 ± 0.05 3.10 ± 0.12 2.15 ± 0.26 4.48 ± 0.71 14.99 ± 1.62
A/A 0.49 ± 0.02 0.10 ± 0.01 0.42 ± 0.08 3.33 ± 0.23 2.81 ± 0.48 5.59 ± 1.26 14.30 ± 2.91
PON1 Glu192Arg
A/A 0.46 ± 0.01 0.12 ± 0.01 0.53 ± 0.03 3.19 ± 0.10 2.27 ± 0.19 5.47 ± 0.53 15.74 ± 1.24
A/G 0.45 ± 0.01 0.12 ± 0.01 0.53 ± 0.04 3.21 ± 0.10 2.56 ± 0.20 4.90 ± 0.54 15.34 ± 1.33
G/G 0.45 ± 0.02 0.09 ± 0.01 0.45 ± 0.07 3.14 ± 0.18 2.53 ± 0.37 5.27 ± 0.87 17.07 ± 2.08
APM1 C-11377G
C/C 0.46 ± 0.01 0.12 ± 0.01 0.52 ± 0.03 3.23 ± 0.08 2.44 ± 0.16 4.91 ± 0.43 15.73 ± 1.01
C/G 0.45 ± 0.01 0.12 ± 0.01 0.52 ± 0.03 3.14 ± 0.09 2.38 ± 0.19 5.70 ± 0.51 15.84 ± 1.17
G/G 0.45 ± 0.05 0.13 ± 0.04 0.66 ± 0.02 3.51 ± 0.58 1.65 ± 1.14 7.80 ± 1.06 18.93 ± 3.62
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Table 4 (Continued)
Polymorphism Intima-media
thickness (mm)
Cross-sectional
compliance
(mm2 mmHg−1)
Cross-sectional
distensibility
(mmHg−1 × 10−2)
Diastolic wall stress
(mmHg× 102)
Incremental elastic
modulus (mmHg× 103)
Flow-mediated
dilation (%)
GTN-mediated
dilation (%)
APM1 G-11391A
G/G 0.46 ± 0.05 0.13 ± 0.01 0.61 ± 0.08 2.94 ± 0.24 1.89 ± 0.41 3.57 ± 1.28 15.11 ± 3.17
A/G 0.45 ± 0.01 0.12 ± 0.04 0.51 ± 0.02 3.22 ± 0.06 2.46 ± 0.13 5.42 ± 0.34 15.83 ± 0.78
CX37 Pro319Ser
C/C 0.46 ± 0.01 0.11 ± 0.01 0.50 ± 0.04 3.10 ± 0.11 2.54 ± 0.22 5.99 ± 0.59 16.57 ± 1.29
C/T 0.46 ± 0.01 0.12 ± 0.01 0.50 ± 0.04 3.17 ± 0.10 2.21 ± 0.21 5.17 ± 0.29 15.39 ± 1.32
T/T 0.45 ± 0.01 0.13 ± 0.01 0.55 ± 0.06 3.37 ± 0.16 2.42 ± 0.32 4.27 ± 0.91 15.90 ± 2.07
NOS3 Glu298Asp
G/G 0.46 ± 0.01 0.11 ± 0.01 0.51 ± 0.03 3.16 ± 0.09 2.44 ± 0.18 5.11 ± 0.52 15.32 ± 1.11
G/T 0.46 ± 0.01 0.12 ± 0.01 0.53 ± 0.04 3.26 ± 0.12 2.36 ± 0.25 5.66 ± 0.66 17.76 ± 1.40
T/T 0.43 ± 0.02 0.11 ± 0.02 0.61 ± 0.01 2.91 ± 0.26 1.92 ± 0.52 4.89 ± 1.40 12.33 ± 2.97
ACE intron 16 I/D
D/D 0.46 ± 0.01 0.11 ± 0.01 0.50 ± 0.03 3.22 ± 0.10 2.52 ± 0.19 5.57 ± 0.53 15.83 ± 1.20
I/D 0.45 ± 0.01 0.12 ± 0.01 0.58 ± 0.04 3.12 ± 0.13 2.14 ± 0.25 5.50 ± 0.69 17.27 ± 1.58
I/I 0.47 ± 0.01 0.12 ± 0.01 0.51 ± 0.06 3.22 ± 0.17 2.37 ± 0.33 4.20 ± 0.93 13.82 ± 2.10
Data are mean± standard error of the mean.
Analyses were performed with an analysis of covariance test using the following covariates: age, sex, Tanner stage, body mass index Z-score, homeostasis model assessment of insulin
resistance, apolipoprotein A1, ferritin, android/gynoid ratio and leptin; no association between any of the genotypes and arterial phenotypes was observed.
ACE: angiotensin I-converting enzyme; AGT: angiotensinogen; AGTR1: angiotensin II type1 receptor; APM1: adiponectin; CX37: connexin; CX3CR1: fractalkine receptor; GTN: glyceryl-
trinitrate; deletion/deletion; D/I: deletion/insertion; I/D: insertion/deletion; MMP3: stromelysin-1; NOS3: nitric oxide synthase 3; PAI-1: plasminogen-activator inhibitor type 1; PON1:
paraoxonase 1.
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to ensure a sufﬁcient number of each genotype to enable
relevant statistical analyses, carry only a modest relative
risk, unlike rare polymorphisms [17]. Conceivably, this small
effect can be masked by prevailing metabolic abnormali-
ties early in life, and become detectable later due to the
progressive pressure on vasculature.
Besides metabolic factors, features of acute-phase acti-
vation and low-grade inﬂammation, demonstrated by a
plasma increase in C-reactive protein, develop with weight
gain and extend the preatherosclerotic burden. Indeed, adi-
pose tissue — and visceral adiposity in particular — is a
key regulator of inﬂammation, coagulation and ﬁbrinolysis
through the secretion of proinﬂammatory cytokines (lep-
tin, resistin, tumour necrosis factor-, interleukin-6, etc.)
and ﬁbrinolytic regulators [30,31]. Recent studies performed
in overweight children have reported a positive association
between proinﬂammatory factors, body mass index, visceral
fat and insulin resistance [25]. Obviously, inﬂammation pro-
motes early arterial changes, as suggested by the positive
association between inﬂammation, endothelial dysfunction
and structural arterial disease demonstrated clearly in chil-
dren [32,33]. In our cohort, 53% of the children had a high
android/gynoid ratio; it is thus conceivable that the associ-
ated inﬂammatory status plays a non-negligible part in the
increased stiffness of the common carotid artery and the
endothelial dysfunction we brought to light several years ago
in this cohort of obese children [1]. As with metabolic fac-
tors, it can also be hypothesized that inﬂammatory variables
override the phenotypical expression of polymorphisms.
Further studies are necessary to conﬁrm our results.
To date, as genetic predisposition to atherosclerosis does
not seem to play a part as early as in childhood, the role
of obesity-associated factors in the occurrence of arterial
alterations in obese children still predominates. Therefore,
the early setup of established treatments for metabolic
complications should certainly help to preserve vasculature
in obese children.
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